Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protection
about
Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of ImmunotherapyOrchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation.Common Ewing sarcoma-associated antigens fail to induce natural T cell responses in both patients and healthy individuals.Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors.Significance of heparanase in cancer and inflammation.T cell-mediated immunotherapy of metastases: state of the art in 2005.Cancer vaccines and tumor dormancy: a long-term struggle between host antitumor immunity and persistent cancer cells?Vaccine-based approaches to squamous cell carcinoma of the head and neck.On the role of antigen in maintaining cytotoxic T-cell memoryBone marrow microenvironment in cancer patients: immunological aspects and clinical implications.Adoptive immunotherapy of metastatic breast cancer: present and future.Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance.Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells.Melanoma vaccines: prospects for the treatment of melanoma.Induction of apoptosis reduces immunogenicity of human T-cell lines in mice.Stabilization of beta-catenin induces lesions reminiscent of prostatic intraepithelial neoplasia, but terminal squamous transdifferentiation of other secretory epithelia.Intra-pinna anti-tumor vaccination with self-replicating infectious RNA or with DNA encoding a model tumor antigen and a cytokine.
P2860
Q26745444-D7805536-7005-4DB1-B339-F10577791318Q34435506-383AD0D9-1BDD-4BDC-80E6-30ADF6307420Q35196739-69F98EA9-D545-4FAD-8374-608D5489DC51Q35232992-85BBEC94-A13F-4BFC-BFA9-5BFDF069162CQ36101233-89EB3925-182F-4CDD-A0ED-86CC97AB6D3EQ36210864-C50A60CB-6B22-40C5-BED8-4DC08E818E0EQ36690273-9689633A-84BA-4280-AF76-1CEFD978CD2FQ36714541-34B3CF85-38AA-4D8A-B333-1CAEE36AB631Q37361402-0B6E7E82-3CC8-4241-AA66-1272BED2543AQ38053396-8169B077-DD21-46E3-B9CA-83801ECF79FCQ38171325-4F42668C-E100-45CE-8BB8-4D48B43CC794Q38599166-8666B6E4-4629-4BDF-90D5-7AC63431DC32Q40411744-CBACFC46-2A15-405B-857C-508069D26995Q40900776-2E44B17F-1FA5-4FFA-85D3-B1CBEE190AB6Q41040620-BE94D989-8089-45F3-882D-87E5937A9D8BQ42521880-2F79471D-BEC5-4663-AEB5-30D47AECBA1AQ45869584-A600F8F6-9B0E-443D-9BF0-85951BB7068E
P2860
Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protection
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Persistence of dormant tumor c ...... -term immunological protection
@ast
Persistence of dormant tumor c ...... -term immunological protection
@en
type
label
Persistence of dormant tumor c ...... -term immunological protection
@ast
Persistence of dormant tumor c ...... -term immunological protection
@en
prefLabel
Persistence of dormant tumor c ...... -term immunological protection
@ast
Persistence of dormant tumor c ...... -term immunological protection
@en
P2093
P2860
P356
P1476
Persistence of dormant tumor c ...... -term immunological protection
@en
P2093
Beckhove P
Griesbach A
Schirrmacher V
P2860
P304
P356
10.1073/PNAS.91.16.7430
P407
P577
1994-08-01T00:00:00Z